Yahoo Web Search

  1. Ads
    related to Breast Cancer Action
  1. The strong earnings performance of pharma companies continued this week with AbbVie ABBV, Merck MRK and Lilly LLY delivering better-than expected results and also boosting their guidance for ...

  2. CymaBay Therapeutics, Inc. (CBAY) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 09 18:01 PM

    It is now my pleasure to introduce your host, Dan Menold, Vice President of Finance for CymaBay Therapeutics. The company assumes no obligation to update or supplement any forward-looking statement ...

  3. INMB: Positive Preliminary Phase 1 Data for INB03…

    Zacks Small Cap Research via Yahoo FinanceAug 21 14:30 PM

    Data from the first two cohorts included two males and four females who were suffering from prostate cancer, ovarian cancer, colon cancer (2), cholangiocarcinoma, or lung ...

  4. Edited Transcript of CELC.OQ earnings conference call or presentation 8-Aug-19 8:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 10 20:34 PM

    And you may recall that the FACT 1 trial is evaluating the safety and efficacy of Genentech's drugs, Herceptin and Perjeta, and chemotherapy in early-stage breast cancer patients ...

  5. Edited Transcript of MGNX earnings conference call or presentation 31-Jul-19 8:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 03 19:44 PM

    We present the results from SOPHIA, our pivotal Phase 3 trial in HER2-positive metastatic breast cancer at ASCO in June. SOPHIA was designed to compare margetuximab plus chemotherapy ...

  6. Edited Transcript of ONTX earnings conference call or presentation 14-Aug-19 1:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 16 21:26 PM

    The JMML program may advance into clinical trials this year, and we are excited about the potential of rigosertib due to its unique mechanism of action in the treatment of these devastating ...

  7. Edited Transcript of FPRX earnings conference call or presentation 7-Aug-19 8:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 16 2:16 AM

    We expect to present data from the monotherapy Phase Ib expansion cohorts at the 20-milligram per kilogram dose in patients with breast, ovarian and endometrial cancers overexpressing ...

  1. Ads
    related to Breast Cancer Action